BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34226098)

  • 21. Validation of a palliative prognostic index to predict life expectancy for terminally ill cancer patients in a hospice consultation setting in Taiwan.
    Cheng WH; Kao CY; Hung YS; Su PJ; Hsieh CH; Chen JS; Wang HM; Chou WC
    Asian Pac J Cancer Prev; 2012; 13(6):2861-6. PubMed ID: 22938474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of the palliative prognostic index in predicting the life expectancy of patients in palliative care: a systematic review and meta-analysis.
    Liu Y; Su L; Wang Y; Liu S; Dong B
    Aging Clin Exp Res; 2018 Dec; 30(12):1417-1428. PubMed ID: 29572610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
    Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
    Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic evaluation in palliative care: final results from a prospective cohort study.
    Ermacora P; Mazzer M; Isola M; Pascoletti G; Gregoraci G; Basile D; De Carlo E; Merlo V; Luz O; Cattaruzza M; Orlando A; Bozza C; Pella N; Sacco CS; Puglisi F; Fasola G; Aprile G
    Support Care Cancer; 2019 Jun; 27(6):2095-2102. PubMed ID: 30229339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction Accuracy Between Terminally Ill Patients' Survival Length and the Estimations Made From Different Medical Staff, a Prospective Cohort Study.
    Chen PY; Huang CH; Peng JK; Yeh SY; Hung SH
    Am J Hosp Palliat Care; 2023 Apr; 40(4):440-446. PubMed ID: 35701084
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score.
    Al-Zahrani AS; El-Kashif AT; Mohammad AA; Elsamany S; Alsirafy SA
    Am J Hosp Palliat Care; 2013 Nov; 30(7):707-11. PubMed ID: 23271407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of clinician prediction of survival in oncology outpatients with advanced cancer.
    Kim YJ; Yoon SJ; Suh SY; Hiratsuka Y; Kang B; Lee SW; Ahn HY; Suh KJ; Kim JW; Kim SH; Kim JW; Lee KW; Kim JH; Lee JS
    PLoS One; 2022; 17(4):e0267467. PubMed ID: 35446910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of Palliative Prognostic Index in Predicting Survival Outcomes in Patients With Hematological Malignancies in the Acute Ward Setting.
    Lee SH; Chou WC; Yang HY; Chen CC; Chang H; Wang PN; Kuo MC; Kao YF; Ho LH; Hsueh SW; Kao CY; Hsueh WH; Hung CY; Hung YS
    Am J Hosp Palliat Care; 2022 May; 39(5):548-554. PubMed ID: 34196220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma.
    Jank BJ; Kadletz L; Schnöll J; Selzer E; Perisanidis C; Heiduschka G
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1487-1492. PubMed ID: 30877423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental Prognostic Value of Apparent Diffusion Coefficient Histogram Analysis in Head and Neck Squamous Cell Carcinoma.
    Li X; Yuan Y; Ren J; Shi Y; Tao X
    Acad Radiol; 2018 Nov; 25(11):1433-1438. PubMed ID: 29599009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
    Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
    Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the accuracy and characteristics of the prognostic prediction of survival of identical terminally ill cancer patients by oncologists and palliative care physicians.
    Urahama N; Sono J; Yoshinaga K
    Jpn J Clin Oncol; 2018 Jul; 48(7):695-698. PubMed ID: 29850870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic tools or clinical predictions: Which are better in palliative care?
    Stone P; Vickerstaff V; Kalpakidou A; Todd C; Griffiths J; Keeley V; Spencer K; Buckle P; Finlay D; Omar RZ
    PLoS One; 2021; 16(4):e0249763. PubMed ID: 33909658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck.
    Chai RL; Rath TJ; Johnson JT; Ferris RL; Kubicek GJ; Duvvuri U; Branstetter BF
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1187-94. PubMed ID: 24076619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
    Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
    Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.